Status:
COMPLETED
At-home Testing Refraction Results With Best Corrected Visual Acuity (BCVA) Outcomes in Adults
Lead Sponsor:
EyeQue Corp.
Conditions:
Visual Impairment
Myopia
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
This study is aimed at examining the BCVA from try-on glasses constructed from measurements from the EyeQue VisionCheck.
Detailed Description
This study is aimed at examining the BCVA from try-on glasses constructed from measurements from the EyeQue VisionCheck. The refraction measurements that users obtain from the VisionCheck are from tes...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or Female
- Ages 30+
- Had purchased an EyeQue refraction device.
- Obtained EGN's from the EyeQue refraction device.
- Ordered Try-On glasses based on EyeQue EyeGlass Numbers.
- Allow use for this study the VisionCheck refraction and try-on glasses measurements, taken prior to study participation.
- Subject Exclusion Criteria, Subjects that by self-report:
- Do not have a command of the English language.
- Lack the ability to follow instructions.
- Lack binocular vision.
- Are Color-blind.
Exclusion
Key Trial Info
Start Date :
April 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2023
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT04820218
Start Date
April 21 2021
End Date
January 20 2023
Last Update
January 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
EyeQue
Newark, California, United States, 94560